DDOG vs SPRY · P/E 292, rev $2.13B vs rev $89.1M
Datadog Inc (DDOG) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Datadog Inc (DDOG) is a software - application company listed on US. It is led by Olivier Pomel.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported DDOG revenue for 2026-06-30 was $2.13B. Net income was $97.1M. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
DDOG currently screens at market cap $47.44B and trailing P/E 292.3. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the DDOG and SPRY stock pages for the full models.
Not investment advice.